EASL Podcasts

1. Talk Liver To Me - Cholangiocarcinoma surveillance in PSC: What should we do now and what’s coming next?

   11 de novembro de 202639 minEpisódio 21A seguir

   Discover how clinicians are approaching screening and surveillance in PSC today. From imaging and endoscopy to the promise of new biomarkers, this episode highlights key tools, ongoing challenges, and future …

   Notas do episódio

   Discover how clinicians are approaching screening and surveillance in PSC today. From imaging and endoscopy to the promise of new biomarkers, this episode highlights key tools, ongoing challenges, and future directions in improving early detection of cholangiocarcinoma.

   Host: Debbie Shawcross (King's College London)
   Guests: Jesús Bañales (Donostia University Hospital), Gideon Hirschfield (The Autoimmune and Rare Liver Disease Programme)

   This episode is also available on EASL Campus: https://easlcampus.eu/tltm/episode-21

   
   

   Thank you to our healthcare industry partners for their support. For more information, please visit EASLCampus.eu.

   This programme is intended for health care professionals only and is provided for educational purposes. EASL does not endorse or promote any medicinal products or medical devices. The views and opinions expressed are those of the speakers and do not necessarily reflect those of EASL.

   All declarations of conflicts of interest are listed on EASL Campus (https://easlcampus.eu/tltm/episode-21).

   EASL is not responsible for the accuracy of any translated versions of this podcast or of subtitles generated automatically by artificial intelligence.

2. EASL DeepDive: AI-Enabled Clinical Trials: Opportunities, Evidence and Oversight

   9 de novembro de 202660 minA seguir

   Artificial intelligence (AI) is opening new opportunities to improve the design, efficiency, and evidence generation of clinical trials. This EASL DeepDive examines its applications in patient selection …

   Notas do episódio

   Artificial intelligence (AI) is opening new opportunities to improve the design, efficiency, and evidence generation of clinical trials. This EASL DeepDive examines its applications in patient selection, stratification, and trial workflows, as well as the emerging role of digital twins in simulating treatment responses. Particular attention is given to the use of AI-enabled real-world data to strengthen clinical evidence, while addressing questions of scientific validity, bias, and practical limitations.

3. Talk Liver To Me - Hepatocellular Carcinoma: Who to screen, when, and how?

   28 de outubro de 202638 minEpisódio 20A seguir

   Hepatocellular carcinoma (HCC) surveillance is a cornerstone of liver disease management, yet uncertainty persists around who to screen, when to initiate surveillance, and which modalities to use. Evolving risk …

   Notas do episódio

   Hepatocellular carcinoma (HCC) surveillance is a cornerstone of liver disease management, yet uncertainty persists around who to screen, when to initiate surveillance, and which modalities to use. Evolving risk profiles and variation across guidelines have added complexity to clinical decision-making. In this podcast, we revisit the fundamentals of HCC screening, focusing on practical, evidence-based approaches to patient selection, timing, and surveillance strategies.

   Host: Mattias Mandorfer (Medical University of Vienna)
   Guests: Peter Jepsen (Aarhus University), Amit Singal (UT Southwestern Medical Center)

   This episode is also available on EASL Campus: https://easlcampus.eu/tltm/episode-20

   
   

   Thank you to our healthcare industry partners for their support. For more information, please visit EASLCampus.eu.

   This programme is intended for health care professionals only and is provided for educational purposes. EASL does not endorse or promote any medicinal products or medical devices. The views and opinions expressed are those of the speakers and do not necessarily reflect those of EASL.

   All declarations of conflicts of interest are listed on EASL Campus (https://easlcampus.eu/tltm/episode-20).

   EASL is not responsible for the accuracy of any translated versions of this podcast or of subtitles generated automatically by artificial intelligence.

4. Talk Liver To Me - Psychohepatology: Are we overlooking mental health in liver disease care?

   14 de outubro de 202638 minEpisódio 19A seguir

   This episode explores psychohepatology, examining the gut–liver–brain axis and the bidirectional links between liver disease and mental health. Discussion covers addiction biology, the impact of trauma and …

   Notas do episódio

   This episode explores psychohepatology, examining the gut–liver–brain axis and the bidirectional links between liver disease and mental health. Discussion covers addiction biology, the impact of trauma and post-traumatic stress disorder (PTSD) on alcohol use, and the high prevalence of depression and anxiety in cirrhosis, highlighting integrated approaches to liver and mental health care.

   Host: Mads Israelsen (Odense University Hospital)
   Guests: Nicola Kalk (South London and Maudsley NHS Foundation Trust), Victoria Kronsten (King's College London)

   This episode is also available on EASL Campus: https://easlcampus.eu/tltm/episode-19

   
   

   Thank you to our healthcare industry partners for their support. For more information, please visit EASLCampus.eu.

   This programme is intended for health care professionals only and is provided for educational purposes. EASL does not endorse or promote any medicinal products or medical devices. The views and opinions expressed are those of the speakers and do not necessarily reflect those of EASL.

   All declarations of conflicts of interest are listed on EASL Campus (https://easlcampus.eu/tltm/episode-19).

   EASL is not responsible for the accuracy of any translated versions of this podcast or of subtitles generated automatically by artificial intelligence.

5. EASL DeepDive: Key Updates in the EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma

   9 de outubro de 20261 h 6 minA seguir

   This EASL Deep Dive explores key updates from the EASL Clinical Practice Guidelines on hepatocellular carcinoma (HCC), with a practical focus on diagnosis and treatment selection. Experts will discuss evolving …

   Notas do episódio

   This EASL Deep Dive explores key updates from the EASL Clinical Practice Guidelines on hepatocellular carcinoma (HCC), with a practical focus on diagnosis and treatment selection. Experts will discuss evolving imaging and diagnostic criteria, patient selection for surgery and locoregional therapies, and how to adapt management according to response to systemic treatment. The session will also highlight the growing importance of multidisciplinary, individualised care across the HCC treatment pathway.

6. Talk Liver To Me - Resmetirom and Semaglutide in MASH: Who, when and how to monitor?

   30 de setembro de 202643 minEpisódio 18A seguir

   This episode of Talk Liver to Me explores the practical use of resmetirom and semaglutide in MASH, based on the 2026 EASL–EASD–EASO Guidance. Experts discuss who may benefit from treatment, when to initiate …

   Notas do episódio

   This episode of Talk Liver to Me explores the practical use of resmetirom and semaglutide in MASH, based on the 2026 EASL–EASD–EASO Guidance. Experts discuss who may benefit from treatment, when to initiate therapy, and how to monitor response and efficacy in clinical practice.

   Host: Debbie Shawcross (EASL)
   Guests: Andreea Ciudin (EASO), Amalia Gastaldelli (EASD), Frank Tacke (EASL)

   This episode is also available on EASL Campus: https://easlcampus.eu/tltm/episode-18

   
   

   Thank you to our healthcare industry partners for their support. For more information, please visit EASLCampus.eu.

   This programme is intended for health care professionals only and is provided for educational purposes. EASL does not endorse or promote any medicinal products or medical devices. The views and opinions expressed are those of the speakers and do not necessarily reflect those of EASL.

   All declarations of conflicts of interest are listed on EASL Campus (https://easlcampus.eu/tltm/episode-18).

   EASL is not responsible for the accuracy of any translated versions of this podcast or of subtitles generated automatically by artificial intelligence.

7. Talk Liver To Me - Africa’s Liver Crisis: Why Is No One Talking About It?

   16 de setembro de 202641 minEpisódio 17A seguir

   Liver disease represents a major and under-recognised public health challenge across Africa, driven by a complex interplay of viral hepatitis, rising metabolic dysfunction-associated steatotic liver disease …

   Notas do episódio

   Liver disease represents a major and under-recognised public health challenge across Africa, driven by a complex interplay of viral hepatitis, rising metabolic dysfunction-associated steatotic liver disease, and a high burden of hepatocellular carcinoma (HCC). Despite this, awareness, surveillance, and access to care remain limited. In this podcast, we explore the evolving epidemiology of liver disease across the continent, highlighting key drivers, regional variations, and gaps in diagnosis and treatment. Why does the burden remain so under-recognised, and what are the priorities for prevention, early detection, and equitable care in Africa?

   Host: Debbie Shawcross (King's College London)
   Guests: Kwame Asomoah (University of Ghana Business School) and Wendy Spearman (University of Cape Town)

   This episode is also available on EASL Campus: https://easlcampus.eu/tltm/episode-17

   
   

   Thank you to our healthcare industry partners for their support. For more information, please visit EASLCampus.eu.

   This programme is intended for health care professionals only and is provided for educational purposes. EASL does not endorse or promote any medicinal products or medical devices. The views and opinions expressed are those of the speakers and do not necessarily reflect those of EASL.

   All declarations of conflicts of interest are listed on EASL Campus (https://easlcampus.eu/tltm/episode-17).

   EASL is not responsible for the accuracy of any translated versions of this podcast or of subtitles generated automatically by artificial intelligence.

8. EASL DeepDive: Utility and challenges of genetic testing in PFIC

   14 de setembro de 20261 h 3 minA seguir

   This webinar explores the role of genetic testing in diagnosing Progressive Familial Intrahepatic Cholestasis (PFIC). Attendees will review key test types, understand the principles behind modern genomic …

   Notas do episódio

   This webinar explores the role of genetic testing in diagnosing Progressive Familial Intrahepatic Cholestasis (PFIC). Attendees will review key test types, understand the principles behind modern genomic technologies, and learn how to position these tests in the diagnostic approach of a person with a suspicion of PFIC and how to navigate common challenges in interpreting genetic results. The session will also highlight emerging trends shaping the future of genetic diagnostics in hepatology.

   Learning objectives

   • Understand the genetic drivers of PFIC and the utility of their testing.
   • Describe basic principles behind modern diagnostic genetic testing relevant to hepatology.
   • Appropriately position genetic testing in the approach of a person suspected to have PFIC.
   • Recognize common challenges in interpreting these genetic findings and linking them with the clinical presentation.
   • Outline emerging trends influencing the future of genetic diagnostics in hepatology

   
   

   This webinar has received educational grants from IPSEN. IPSEN has had no input into the programme, content, or faculty selection.

9. Talk Liver To Me - What are the Dos and Don'ts in Acute Liver Failure?

   2 de setembro de 202639 minEpisódio 16A seguir

   Acute liver failure (ALF) is a rare but life-threatening condition requiring rapid recognition and decisive management. Early decisions around investigation, escalation, and referral can significantly impact …

   Notas do episódio

   Acute liver failure (ALF) is a rare but life-threatening condition requiring rapid recognition and decisive management. Early decisions around investigation, escalation, and referral can significantly impact outcomes. Despite advances in care, variation in practice and avoidable pitfalls remain common. In this podcast, we take a practical, case-based approach to the key “dos and don’ts” in ALF management, focusing on early diagnosis, initial stabilisation, appropriate investigations, and timely referral to specialist centres. What should clinicians prioritise, what should be avoided, and how can we optimise care in the critical early stages of acute liver failure?

   Host: Mattias Mandorfer (Medical University of Vienna)
   Guests: William Bernal (King's College London), Nigel Heaton (King's College London)

   This episode is also available on EASL Campus: https://easlcampus.eu/tltm/episode-16

   
   

   Thank you to our healthcare industry partners for their support. For more information, please visit EASLCampus.eu.

   This programme is intended for health care professionals only and is provided for educational purposes. EASL does not endorse or promote any medicinal products or medical devices. The views and opinions expressed are those of the speakers and do not necessarily reflect those of EASL.

   All declarations of conflicts of interest are listed on EASL Campus (https://easlcampus.eu/tltm/episode-16).

   EASL is not responsible for the accuracy of any translated versions of this podcast or of subtitles generated automatically by artificial intelligence.

10. Talk Liver To Me - Endohepatology: Added value or added complexity?

    19 de agosto de 202642 minEpisódio 15A seguir

    Endohepatology is emerging as a novel approach to liver disease assessment, with the potential to combine EUS-guided liver biopsy, portal pressure measurement, and variceal evaluation within a single session …

    Notas do episódio

    Endohepatology is emerging as a novel approach to liver disease assessment, with the potential to combine EUS-guided liver biopsy, portal pressure measurement, and variceal evaluation within a single session. This “one-stop shop” model could streamline diagnostic pathways and enable integrated, real-time clinical decision-making. However, this innovation comes at a time when hepatology is moving increasingly towards non-invasive testing strategies. Questions therefore remain around its appropriateness, clinical utility, and feasibility in routine practice. In this podcast, we explore whether this approach represents meaningful progress or premature adoption, examining current evidence, potential benefits, and practical challenges.

    This episode is produced in collaboration with the European Society of Gastrointestinal Endoscopy (ESGE).

    Host: Tom Marjot (King's College London)
    Guests: Juan Abraldes (University of Alberta), Hannah van Malenstein (University Hospital Leuven)

    This episode is also available on EASL Campus: https://easlcampus.eu/tltm/episode-15

    
    

    Thank you to our healthcare industry partners for their support. For more information, please visit EASLCampus.eu.

    This programme is intended for health care professionals only and is provided for educational purposes. EASL does not endorse or promote any medicinal products or medical devices. The views and opinions expressed are those of the speakers and do not necessarily reflect those of EASL.

    All declarations of conflicts of interest are listed on EASL Campus (https://easlcampus.eu/tltm/episode-15).

    EASL is not responsible for the accuracy of any translated versions of this podcast or of subtitles generated automatically by artificial intelligence.

11. Talk Liver To Me - What nobody tells you about starting a research group

    5 de agosto de 202633 minEpisódio 14A seguir

    Early-career researchers and clinician-scientists play a central role in advancing hepatology research and innovation, yet the transition to independence often comes with challenges that extend beyond …

    Notas do episódio

    Early-career researchers and clinician-scientists play a central role in advancing hepatology research and innovation, yet the transition to independence often comes with challenges that extend beyond scientific expertise. Building a research programme, leading teams, securing funding, and developing a sustainable academic career require skills that are rarely addressed during formal training. In this podcast, we explore the realities of early academic leadership, focusing on the practical and professional challenges faced during the first years of research independence.

    Host: Carolin Schneider (RWTH Aachen University)
    Guests: Pierre-Emmanuel Rautou (Hôpital Beaujon, APHP & Université Paris Cité), Mathias Heikenwälder (University of Tübingen)

    This episode is also available on EASL Campus: https://easlcampus.eu/tltm/episode-14

    
    

    Thank you to our healthcare industry partners for their support. For more information, please visit EASLCampus.eu.

    This programme is intended for health care professionals only and is provided for educational purposes. EASL does not endorse or promote any medicinal products or medical devices. The views and opinions expressed are those of the speakers and do not necessarily reflect those of EASL.

    All declarations of conflicts of interest are listed on EASL Campus (https://easlcampus.eu/tltm/episode-14).

    EASL is not responsible for the accuracy of any translated versions of this podcast or of subtitles generated automatically by artificial intelligence.

12. Talk Liver To Me - Global Updates on Hepatitis E: How Should We Manage Acute and Chronic Infection?

    22 de julho de 202647 minEpisódio 13A seguir

    Hepatitis E is a globally prevalent infection with diverse clinical manifestations, ranging from self-limiting acute hepatitis to chronic infection in immunosuppressed patients. Its presentation and …

    Notas do episódio

    Hepatitis E is a globally prevalent infection with diverse clinical manifestations, ranging from self-limiting acute hepatitis to chronic infection in immunosuppressed patients. Its presentation and epidemiology vary significantly between regions, influencing diagnostic and management strategies. Despite increasing recognition, uncertainty remains around who to test, when to treat, and how to manage chronic disease effectively. In this podcast, we bring together perspectives from Europe and Asia to explore key differences in clinical practice, emerging evidence, and practical approaches to care.

    Host: Thomas Marjot (Kings College London)

    Guests: Tobias Böttler (Universitätsklinikum Freiburg), Siddharth Sridhar (University of Hong Kong)

    
    

    This episode is also available on EASL Campus: https://easlcampus.eu/tltm/episode-13

    Thank you to our healthcare industry partners for their support. For more information, please visit EASLCampus.eu.

    This programme is intended for health care professionals only and is provided for educational purposes. EASL does not endorse or promote any medicinal products or medical devices. The views and opinions expressed are those of the speakers and do not necessarily reflect those of EASL.

    All declarations of conflicts of interest are listed on EASL Campus (https://easlcampus.eu/tltm/episode-13).

    EASL is not responsible for the accuracy of any translated versions of this podcast or of subtitles generated automatically by artificial intelligence.

13. Talk Liver To Me - MASLD and HFpEF: Do We Need a Shared Treatment Strategy?

    8 de julho de 202639 minEpisódio 12A seguir

    Metabolic dysfunction-associated steatotic liver disease (MASLD) and heart failure with preserved ejection fraction (HFpEF) are increasingly recognised as manifestations of a shared cardiometabolic disorder …

    Notas do episódio

    Metabolic dysfunction-associated steatotic liver disease (MASLD) and heart failure with preserved ejection fraction (HFpEF) are increasingly recognised as manifestations of a shared cardiometabolic disorder. Driven by overlapping risk factors such as obesity and insulin resistance, these conditions frequently coexist and may interact through liver–heart crosstalk. Despite this, they are typically managed separately, with limited disease-specific therapies and suboptimal outcomes. In this podcast, we explore whether a more integrated approach could improve diagnosis, risk stratification, and treatment.

    Host: Cyrielle Caussy (Lyon 1 University and Hospices Civils de Lyon)

    Guests: Zannad Faiez (University of Lorraine, Nancy), Pinelopi Manousou (Imperial College London)

    This episode is also available on EASL Campus: https://easlcampus.eu/tltm/episode-12

    Talk Liver To Me is supported by Opella. Opella has had no input to the content of this programme.

    This programme is intended for health care professionals only and is provided for educational purposes. EASL does not endorse or promote any medicinal products or medical devices. The views and opinions expressed are those of the speakers and do not necessarily reflect those of EASL.

    All declarations of conflicts of interest are listed on EASL Campus (https://easlcampus.eu/tltm/episode-12).

    EASL is not responsible for the accuracy of any translated versions of this podcast or of subtitles generated automatically by artificial intelligence.

14. A joint EASL-ERN RARE-LIVER DeepDive – Wilson’s disease: a 2026 update

    3 de julho de 20261 h 5 minA seguir

    The following objectives will be addressed in this EASL Deep Dive episode:Have a profound knowledge of the pitfalls, limitations and difficulty of interpretation of the different tests of copper metabolism and …

    Notas do episódio

    The following objectives will be addressed in this EASL Deep Dive episode:

    • Have a profound knowledge of the pitfalls, limitations and difficulty of interpretation of the different tests of copper metabolism and liver copper assessments
    • Be able to establish a diagnostic approach to Wilson’s disease, integrating clinical, laboratory, genetic and imaging tools
    • Have a good understanding of the different treatment modalities, how to position them in the disease course, how to monitor treatment and what to expect as a result/outcome?

    This EASL DeepDive webinar is supported by Orphalan and Univar Solutions. Orphalan and Univar Solutions have had no input into the content of this EASL DeepDive.

15. Talk Liver To Me - Chasing the perfect SLD preclinical model

    24 de junho de 202634 minEpisódio 11A seguir

    Steatotic liver disease (SLD) research relies heavily on preclinical models, yet no single model can fully capture the complexity of human disease. In this episode, we explore the new EASL position paper on …

    Notas do episódio

    Steatotic liver disease (SLD) research relies heavily on preclinical models, yet no single model can fully capture the complexity of human disease. In this episode, we explore the new EASL position paper on preclinical SLD models. From MASLD and MetALD to organoids and precision-cut liver slices, we discuss the strengths, limitations, and translational relevance of today's most widely used models. How do we choose the right model, and are we any closer to finding the perfect one?

    Based on EASL position paper on preclinical models of steatotic liver disease

    Host: Rui Castro (University of Lisbon)
    Speakers: Mathias Heikenwälder (University of Tübingen) and Suchira Gallage (University of Tübingen)

    This episode is also available on EASL Campus: https://easlcampus.eu/tltm/episode-11

    This programme is intended for health care professionals only and is provided for educational purposes. EASL does not endorse or promote any medicinal products or medical devices. The views and opinions expressed are those of the speakers and do not necessarily reflect those of EASL.

    All declarations of conflicts of interest are listed on EASL Campus (https://easlcampus.eu/tltm/episode-11).

    EASL is not responsible for the accuracy of any translated versions of this podcast or of subtitles generated automatically by artificial intelligence.

16. Talk Liver To Me - Haemochromatosis in 2026: Who Needs Testing and Who Needs Treatment?

    10 de junho de 202643 minEpisódio 10A seguir

    Haemochromatosis remains one of the most common inherited metabolic disorders, yet it is frequently underdiagnosed and inconsistently managed in clinical practice. With widespread use of iron studies and …

    Notas do episódio

    Haemochromatosis remains one of the most common inherited metabolic disorders, yet it is frequently underdiagnosed and inconsistently managed in clinical practice. With widespread use of iron studies and genetic testing, clinicians are increasingly faced with questions around interpretation, penetrance, and clinical significance. In this podcast, we explore current challenges in diagnosis and management, focusing on who should be tested, how to interpret results, and which patients benefit from intervention in modern hepatology practice.

    Host: Thomas Marjot (King's College, London)
    Speakers: John Ryan (Beaumont Hospital, Dublin) and Heinz Zoller (Medical University of Innsbruck)

    This episode is also available on EASL Campus: https://easlcampus.eu/tltm/episode-10

17. Talk Liver To Me - Liver Transplantation: Rise of the machines

    13 de maio de 202637 minEpisódio 9A seguir

    In this episode, we discuss the first pig-to-human liver xenotransplantation and the breakthroughs behind the revival of xenotransplantation, examining its potential and remaining challenges. We also explore …

    Notas do episódio

    In this episode, we discuss the first pig-to-human liver xenotransplantation and the breakthroughs behind the revival of xenotransplantation, examining its potential and remaining challenges. We also explore the accelerating field of machine perfusion, clarifying different approaches and reviewing the evidence supporting their role in organ assessment, optimisation, and DCD utilisation.

    Host: Sarwa Darwish Murad (Erasmus University Rotterdam)
    Speakers: Jeroen de Jonge (Erasmus University Rotterdam) and Matthew Armstrong (University Hospital Birmingham)

    This episode is also available on EASL Campus: https://easlcampus.eu/tltm/episode-09

18. Talk Liver To Me - Spontaneous Bacterial Peritonitis: Time to Rethink the Rules?

    29 de abril de 202635 minEpisódio 8A seguir

    Spontaneous bacterial peritonitis (SBP) remains a major complication of cirrhosis - but rising antimicrobial resistance and emerging data are challenging long-standing practices.In this episode, we review …

    Notas do episódio

    Spontaneous bacterial peritonitis (SBP) remains a major complication of cirrhosis - but rising antimicrobial resistance and emerging data are challenging long-standing practices.

    In this episode, we review current evidence on primary and secondary prophylaxis, resistance patterns, albumin use, and treatment strategies. How should clinicians balance prevention with antimicrobial stewardship? And where might practice need to evolve in 2026?

    Host: Thomas Marjot (King's College London)
    Speakers: Bogdan Procopet (Institute of Gastroenterology and Hepatology, Cluj-Napoca) and Alastair O'Brien (Royal Free Hospital, London)

    This episode is also available on EASL Campus: https://easlcampus.eu/tltm/episode-08

19. EASL DeepDive: Key Updates in the EASL Clinical Practice Guidelines on extrahepatic Cholangiocarcinoma (eCCA)

    23 de abril de 20261 h 7 minA seguir

    In this EASL DeepDive webinar, the expert panel presents and explains the key studies behind the latest recommendations included in the EASL Clinical Practice Guidelines on the management of extrahepatic …

    Notas do episódio

    In this EASL DeepDive webinar, the expert panel presents and explains the key studies behind the latest recommendations included in the EASL Clinical Practice Guidelines on the management of extrahepatic cholangiocarcinoma.

    Learning Objectives

    • To identify patients at risk for eCCA, and review the current tools and strategies for its surveillance, diagnosis, staging, and classification
    • To define the optimal candidates for resection and liver transplantation, and discuss challenges in the surgical management of eCCA
    • To discuss the role of systemic therapy in the management of eCCA across all disease stages (including neoadjuvant, adjuvant, and palliative settings)

    Faculty

    • Luca Maroni - Moderator
    • Julie Heimbach - Speaker
    • Anna Saborowski - Speaker
    • Lars Aabakken - Speaker

20. Talk Liver To Me - World Liver Day: Making Lifestyle Change Possible

    15 de abril de 202635 minEpisódio 7A seguir

    This episode explores the role of lifestyle in preventing and managing liver disease, including MASLD/MASH. Our experts discuss the impact of diet and physical activity, why lifestyle change can be difficult to …

    Notas do episódio

    This episode explores the role of lifestyle in preventing and managing liver disease, including MASLD/MASH. Our experts discuss the impact of diet and physical activity, why lifestyle change can be difficult to start and sustain, and why small, achievable steps can still make a meaningful difference.

    Host: Cyrielle Caussy
    Speakers: Kate Hallsworth and Manuel Romero-Gómez

    This episode is also available on EASL Campus: https://easlcampus.eu/tltm/episode-07

21. EASL DeepDive: The Pursuit of a Cure: HCC Management Strategies

    9 de abril de 20261 h 15 minA seguir

    Hepatocellular carcinoma (HCC) is responsible for 75% of all primary liver cancers and is the third most prevalent cause of cancer death worldwide, with 900,000 new cases diagnosed each year. Many patients are …

    Notas do episódio

    Hepatocellular carcinoma (HCC) is responsible for 75% of all primary liver cancers and is the third most prevalent cause of cancer death worldwide, with 900,000 new cases diagnosed each year. Many patients are diagnosed at an advanced stage, making curative treatment difficult.

    In this DeepDive Webinar, you’ll be guided through the latest advances in hepatocellular carcinoma management, from the rising impact of immunotherapy combinations to evolving approaches in intermediate-stage disease.

    This EASL DeepDive webinar is supported by Bayer AG. Bayer AG has had no input into the content of this EASL DeepDive.

    Learning Objectives

    • What are strategies to optimise surveillance and early diagnosis of hepatocellular carcinoma
    • What are the optimal candidates for surgery (including liver transplantation) and locoregional therapies (alone or combined with immunotherapy)
    • Optimal selection of systemic front-line regimens and treatment sequencing after first-line immunotherapy

    Faculty

    • Manon Allaire - Moderator
    • Fabio Piscaglia - Speaker
    • Antonio D'Alessio - Speaker
    • Anna Saborowski - Speaker

22. EASL DeepDive: EASL Clinical Practice Guidelines on the management of autoimmune hepatitis

    9 de abril de 20261 h 19 minA seguir

    In this EASL DeepDive, experts will discuss the latest advances in the EASL Clinical Practice Guidelines on the management of autoimmune hepatitis, published in the "Journal of Hepatology" in 2025.Learning …

    Notas do episódio

    In this EASL DeepDive, experts will discuss the latest advances in the EASL Clinical Practice Guidelines on the management of autoimmune hepatitis, published in the "Journal of Hepatology" in 2025.

    Learning objectives

    • Select induction and maintenance treatment strategies aimed at achieving complete biochemical response
    • Recognise and manage disease flares, treatment intolerance, and suboptimal response in autoimmune hepatitis
    • Understand tailored approaches to autoimmune hepatitis management in specific patient groups

    Faculty

    • Mária Papp - Moderator
    • Michael Heneghan - Speaker
    • George Dalekos - Speaker
    • Maria Carlota Londoño - Speaker

23. EASL DeepDive: Key Changes in the New EASL HBV Guidelines

    9 de abril de 20261 h 16 minA seguir

    In this EASL DeepDive, experts will discuss the latest advances in the EASL Clinical Practice Guidelines on the management of hepatitis B virus infection, published in the "Journal of Hepatology" in …

    Notas do episódio

    In this EASL DeepDive, experts will discuss the latest advances in the EASL Clinical Practice Guidelines on the management of hepatitis B virus infection, published in the "Journal of Hepatology" in 2025.

    Learning objectives

    • Understand the updated EASL recommendations for initiating and discontinuing antiviral therapy in chronic hepatitis B, including key differences with other HBV guidelines. Participants will be able to identify treatment indications and make informed decisions about when and how to stop antiviral therapy.
    • Learn how to monitor patients with hepatitis B across different clinical scenarios, including those not on treatment, those receiving antiviral therapy, surveillance for hepatocellular carcinoma, risk of reactivation, and response to vaccination, in alignment with the new EASL guidelines.
    • Explore future directions in the management of chronic hepatitis B as outlined in the EASL guidelines, including advances in nomenclature and antiviral therapies under development.

    Faculty

    • Markus Cornberg - Moderator
    • Maud Lemoine - Speaker
    • Sabela Lens - Speaker
    • Jerzy Jaroszewicz - Speaker

24. Talk Liver To Me - Baveno VIII: The takeaways you shouldn’t miss

    1 de abril de 202637 minA seguir

    In this episode our speakers share their immediate impressions and break down the key highlights shaping the management of portal hypertension and advanced liver disease. What has truly changed in practice? …

    Notas do episódio

    In this episode our speakers share their immediate impressions and break down the key highlights shaping the management of portal hypertension and advanced liver disease. What has truly changed in practice? Where was consensus reached and where do controversies remain?

    Tune in for a clear, practical overview of what you need to know from Baveno VIII.

    Host: Thomas Marjot
    Speakers: Mattias Mandorfer and Cristina Ripoll

    This episode is also available on EASL Campus: https://easlcampus.eu/tltm/episode-06

25. Talk Liver To Me - Updated BCLC Guidelines for HCC: Protocolised or Patient-Centred Care?

    18 de março de 202630 minEpisódio 5A seguir

    This episode unpacks the updated BCLC guidelines for hepatocellular carcinoma management. Experts discuss the strengths and limitations of the BCLC model in an era of rapidly evolving systemic therapies and …

    Notas do episódio

    This episode unpacks the updated BCLC guidelines for hepatocellular carcinoma management. Experts discuss the strengths and limitations of the BCLC model in an era of rapidly evolving systemic therapies and personalised care, sharing real-world examples of when the algorithm helps and when clinical practice diverges.

    Host: Mattias Mandorfer
    Speakers: Marco Sanduzzi, Lorenza Rimassa

    This episode is also available on EASL Campus: https://easlcampus.eu/tltm/episode-05

26. Talk Liver To Me - When Cure isn’t the only goal: Palliative Care in Advanced Liver Disease

    4 de março de 202635 minEpisódio 4A seguir

    As deaths from advanced chronic liver disease rise, many patients never receive timely palliative care.In this episode, we explore why early, holistic support is essential in advanced liver disease and HCC, and …

    Notas do episódio

    As deaths from advanced chronic liver disease rise, many patients never receive timely palliative care.

    In this episode, we explore why early, holistic support is essential in advanced liver disease and HCC, and unpack key recommendations from the new EASL Position Paper to help reduce suffering and improve quality of life.

    Host: Debbie Shawcross
    Speakers: Patrizia-Künzler-Heule, Sumita Verma

    This episode is also available on EASL Campus: https://easlcampus.eu/tltm/episode-04

27. Talk Liver To Me - MetALD in Practice: Does it Change How We Treat Patients?

    18 de fevereiro de 202641 minEpisódio 3A seguir

    This episode explores whether MetALD is a meaningful clinical entity or an unnecessary complication. Experts discuss the overlap between metabolic dysfunction and alcohol use, the challenges of applying the …

    Notas do episódio

    This episode explores whether MetALD is a meaningful clinical entity or an unnecessary complication. Experts discuss the overlap between metabolic dysfunction and alcohol use, the challenges of applying the MetALD definition in practice, and its impact on classification, guidelines, drug development, and patient care.

    Host: Thomas Marjot
    Speakers: Mary Rinella , Aleksander Krag

    This episode is also available on EASL Campus: https://easlcampus.eu/tltm/episode-03

28. Talk Liver To Me - From imposter syndrome to influence: Women shaping hepatology

    4 de fevereiro de 202637 minEpisódio 2A seguir

    EASL’s Secretary General and Vice Secretary General share an open conversation on the challenges and opportunities for women in hepatology. The episode explores the role of mentorship across career stages and …

    Notas do episódio

    EASL’s Secretary General and Vice Secretary General share an open conversation on the challenges and opportunities for women in hepatology. The episode explores the role of mentorship across career stages and reflects on the journey toward EASL’s first female Secretary General, offering insights on leadership and change in the field.

    Host: Maja Thiele
    Speakers: Debbie Shawcross, Ana Lleo

    This episode is also available on EASL Campus: https://easlcampus.eu/tltm/episode-02

    Trecho (0:30)

29. Talk Liver To Me - Hepatology Ward Rounds: East Meets West

    21 de janeiro de 202636 minEpisódio 1A seguir

    In collaboration with the Indian National Association for the Study of the Liver (INASL), hepatologists from South Asia and North America/Europe take listeners inside their liver wards to explore how regional …

    Notas do episódio

    In collaboration with the Indian National Association for the Study of the Liver (INASL), hepatologists from South Asia and North America/Europe take listeners inside their liver wards to explore how regional context shapes acute liver care. From admission patterns to alcohol use, infections, DILI, nutrition, and access to transplant, the episode highlights key differences and opportunities for shared learning across regions.

    This episode is also available on EASL Campus: https://easlcampus.eu/tltm/episode-01

    Transcrição

30. EASL Studio Podcast: Collaborating across disciplines to find the best solution for people living with PBC

    18 de dezembro de 202533 minTemporada 9 · Episódio 12A seguir

    This EASL Studio episode brings key insights from the 2025 EASL–AASLD Consensus Conference on Primary Biliary Cholangitis (PBC).Experts explore the use of surrogate endpoints, the challenges in current trial …

    Notas do episódio

    This EASL Studio episode brings key insights from the 2025 EASL–AASLD Consensus Conference on Primary Biliary Cholangitis (PBC).

    Experts explore the use of surrogate endpoints, the challenges in current trial design and regulation, the value of real-world evidence, and how quality-of-life assessment can support future pathways.

    
    

    Moderator: David Jones

    Speakers: Marco Carbone, Bettina Hansen, and Ana Lleo

    
    

    All EASL Studio Podcasts are available on EASL Campus.

    Click here to see all EASL Video Podcasts on Apple Podcasts.

Aqui estão os 40 episódios mais recentes de 168. Os mais antigos estão no feed do podcast.